{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:54:46Z","timestamp":1781877286590,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006452","name":"University of Miyazaki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006452","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12153-7","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:23:16Z","timestamp":1781875396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dapagliflozin confers protection against ferroptosis in cardiomyocyte via the inhibition of interferon-gamma pathway"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7804-4487","authenticated-orcid":false,"given":"Rizki Radhitya","family":"Menaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-4821","authenticated-orcid":false,"given":"Harishkumar","family":"Madhyastha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2086-3503","authenticated-orcid":false,"given":"Radha","family":"Madhyastha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9973-3328","authenticated-orcid":false,"given":"Sowmiya","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6422-527X","authenticated-orcid":false,"given":"Tomoko","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-9177","authenticated-orcid":false,"given":"Renan","family":"Sukmawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7240-9062","authenticated-orcid":false,"given":"Yuichi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-411X","authenticated-orcid":false,"given":"Nozomi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"12153_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, Wang F (2023) The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol 20:7\u201323. https:\/\/doi.org\/10.1038\/s41569-022-00735-4","journal-title":"Nat Rev Cardiol"},{"key":"12153_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22:266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12153_CR3","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3390\/cells11172726","volume":"11","author":"L-H Xie","year":"2022","unstructured":"Xie L-H, Fefelova N, Pamarthi SH, Gwathmey JK (2022) Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease. Cells 11:2726. https:\/\/doi.org\/10.3390\/cells11172726","journal-title":"Cells"},{"key":"12153_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10565-024-09853-w","volume":"40","author":"W Fang","year":"2024","unstructured":"Fang W, Xie S, Deng W (2024) Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future. Cell Biol Toxicol 40:17. https:\/\/doi.org\/10.1007\/s10565-024-09853-w","journal-title":"Cell Biol Toxicol"},{"key":"12153_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/nejmoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP et al (2019) Dapagliflozin and cardiovascular outcomes in Type 2 diabetes. N Engl J Med 380:347\u2013357. https:\/\/doi.org\/10.1056\/nejmoa1812389","journal-title":"N Engl J Med"},{"key":"12153_CR6","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 373:2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"12153_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW et al (2017) Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med 377:644\u2013657. https:\/\/doi.org\/10.1056\/NEJMoa1611925","journal-title":"N Engl J Med"},{"key":"12153_CR8","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE et al (2019) Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med 381:1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303","journal-title":"N Engl J Med"},{"key":"12153_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/nejmoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J et al (2020) Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med 383:1413\u20131424. https:\/\/doi.org\/10.1056\/nejmoa2022190","journal-title":"N Engl J Med"},{"key":"12153_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12872-025-04992-2","volume":"25","author":"D Semirani-Nezhad","year":"2025","unstructured":"Semirani-Nezhad D, Soleimani H, Taebi M et al (2025) Early initiation of SGLT2 inhibitors in acute myocardial infarction and cardiovascular outcomes, an updated systematic review and meta-analysis. BMC Cardiovasc Disord 25:527. https:\/\/doi.org\/10.1186\/s12872-025-04992-2","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"12153_CR11","doi-asserted-by":"publisher","first-page":"26136","DOI":"10.31083\/RCM26136","volume":"26","author":"S Hu","year":"2025","unstructured":"Hu S, Tang T, Yu Q, Tong X, You Y, Zhang S, Chen C, Tang J, Wang C, Wang H, Fu X, Chen J, Zhang X, Wang M, Liu L (2025) Cardiovascular outcome of the SGLT2 inhibitor in acute myocardial infarction: a meta-analysis. Rev Cardiovasc Med 26(2):26136. https:\/\/doi.org\/10.31083\/RCM26136","journal-title":"Rev Cardiovasc Med"},{"key":"12153_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.768214","author":"YW Yu","year":"2021","unstructured":"Yu YW, Que JQ, Liu S et al (2021) Sodium-glucose co-transporter-2 inhibitor of dapagliflozin attenuates myocardial ischemia\/reperfusion injury by limiting NLRP3 inflammasome activation and modulating autophagy. Front Cardiovasc Med. . 8: https:\/\/doi.org\/10.3389\/fcvm.2021.768214. 8:","journal-title":"Front Cardiovasc Med"},{"key":"12153_CR13","doi-asserted-by":"publisher","first-page":"123798","DOI":"10.1016\/j.lfs.2025.123798","volume":"377","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhou C, Chen G, Li Y, Liu X, Luo S (2025) Dapagliflozin promotes metabolic reprogramming against myocardial infarction through the MAPK-FOXO3-STC1 and HIF-1a-STC1 pathways. Life Sci 377:123798. https:\/\/doi.org\/10.1016\/j.lfs.2025.123798","journal-title":"Life Sci"},{"key":"12153_CR14","doi-asserted-by":"publisher","unstructured":"Lu Q, Yao X, Zheng H, Ou J, You J, Zhang Q, Guo W, Xu J, Geng L, Liu Q, Pei N, Gong Y, Zhu H, Shen Y (2024) SS-31 modification alleviates ferroptosis induced by superparamagnetic iron oxide nanoparticles in hypoxia\/reoxygenation cardiomyocytes. Heliyon 10(20):e38584 https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38584. Heliyon 10:","DOI":"10.1016\/j.heliyon.2024.e38584"},{"key":"12153_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2023.05.027","volume":"205","author":"T Cao","year":"2023","unstructured":"Cao T, Zhou J, Liu Q et al (2023) Interferon-\u03b3 induces salivary gland epithelial cell ferroptosis in Sjogren\u2019s syndrome via JAK\/STAT1-mediated inhibition of system Xc-. Free Radic Biol Med 205:116\u2013128. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.05.027","journal-title":"Free Radic Biol Med"},{"key":"12153_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","volume":"110","author":"R Kong","year":"2021","unstructured":"Kong R, Wang N, Han W et al (2021) IFN\u03b3-mediated repression of system xc\u2013 drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. J Leukoc Biol 110:301\u2013314","journal-title":"J Leukoc Biol"},{"key":"12153_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Fang Z-M, Yi X et al (2023) The interaction between ferroptosis and inflammatory signaling pathways. Cell Death Dis 14:205. https:\/\/doi.org\/10.1038\/s41419-023-05716-0","journal-title":"Cell Death Dis"},{"key":"12153_CR18","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/ijms25021314","volume":"25","author":"T-H Chen","year":"2024","unstructured":"Chen T-H, Wang H-C, Chang C-J, Lee S-Y (2024) Mitochondrial glutathione in cellular redox homeostasis and disease manifestation. Int J Mol Sci 25:1314. https:\/\/doi.org\/10.3390\/ijms25021314","journal-title":"Int J Mol Sci"},{"key":"12153_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB (2018) IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol 18:545\u2013558. https:\/\/doi.org\/10.1038\/s41577-018-0029-z","journal-title":"Nat Rev Immunol"},{"key":"12153_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","volume":"31","author":"X Hu","year":"2009","unstructured":"Hu X, Ivashkiv LB (2009) Cross-regulation of Signaling Pathways by Interferon-\u03b3: Implications for Immune Responses and Autoimmune Diseases. Immunity 31:539\u2013550. https:\/\/doi.org\/10.1016\/j.immuni.2009.09.002","journal-title":"Immunity"},{"key":"12153_CR21","doi-asserted-by":"publisher","first-page":"1078205","DOI":"10.3389\/fphar.2023.1078205","volume":"14","author":"W Chen","year":"2023","unstructured":"Chen W, Zhang Y, Wang Z, Tan M, Lin J, Qian X, Li H, Jiang T (2023) Dapagliflozin alleviates myocardial ischemia\/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition. Front Pharmacol 14:1078205. https:\/\/doi.org\/10.3389\/fphar.2023.1078205","journal-title":"Front Pharmacol"},{"key":"12153_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10565-020-09530-8","volume":"37","author":"Y Song","year":"2021","unstructured":"Song Y, Wang B, Zhu X et al (2021) Human umbilical cord blood\u2013derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biol Toxicol 37:51\u201364. https:\/\/doi.org\/10.1007\/s10565-020-09530-8","journal-title":"Cell Biol Toxicol"},{"issue":"11","key":"12153_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41419-019-2061-8","volume":"10","author":"TJ Park","year":"2019","unstructured":"Park TJ, Park JH, Lee GS, Lee JY, Shin JH, Kim MW, Kim YS, Kim JY, Oh KJ, Han BS, Kim WK, Ahn Y, Moon JH, Song J, Bae KH, Kim DH, Lee EW, Lee SC (2019) Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death Dis 10(11):835. https:\/\/doi.org\/10.1038\/s41419-019-2061-8","journal-title":"Cell Death Dis"},{"key":"12153_CR24","doi-asserted-by":"publisher","first-page":"1011669","DOI":"10.3389\/fendo.2022.1011669","volume":"13","author":"S Du","year":"2022","unstructured":"Du S, Shi H, Xiong L, Wang P, Shi Y (2022) Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Front Endocrinol (Lausanne) 13:1011669. https:\/\/doi.org\/10.3389\/fendo.2022.1011669","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"12153_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","volume":"20","author":"V De Quagliariello","year":"2021","unstructured":"Quagliariello V, De Laurentiis M, Rea D, Barbieri A, Monti MG, Carbone A, Paccone A, Altucci L, Conte M, Canale ML, Botti G, Maurea N (2021) The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin. Cardiovasc Diabetol 20(1):150. https:\/\/doi.org\/10.1186\/s12933-021-01346-y","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"12153_CR26","doi-asserted-by":"publisher","first-page":"101334","DOI":"10.1016\/j.xcrm.2023.101334","volume":"4","author":"Q Wu","year":"2023","unstructured":"Wu Q, Yao Q, Hu T, Yu J, Jiang K, Wan Y, Tang Q (2023) Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2. Cell Rep Med 4(12):101334. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101334","journal-title":"Cell Rep Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12153-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12153-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12153-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:23:22Z","timestamp":1781875402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12153-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12153"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12153-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"959"}}